GSK Acquires Nuvalent to Expand Oncology Pipeline | Lucid Diligence Brief
GSK strengthens its oncology portfolio with Nuvalent acquisition, adding…
ELCC 2025 Preview: Key Lung Cancer Highlights to Watch
ELCC 2025 at a glance Looking toward ELCC 2025, LucidQuest highlights…

